339P Impact of blood glucose levels on the efficacy of everolimus-exemestane in patients with advanced HR-positive/HER2 negative breast cancer: The EVERMET studyClaudio Vernieri,Federico Nichetti, Valentina Guarneri, Enrico Cortesi,Luca Moscetti,L. Del Mastro, A. Fabbri,Giuseppe Curigliano,Filippo Montemurro,Agnese Losurdo,Daniele Generali,A. Fabi,Rebecca Pedersini, Mariangela Ciccarese,A. Rocca,G. Arpino,N. La Verde, F. Puglisi,Luigi Mariani,F. de BraudAnnals of Oncology（2020）引用 0|浏览63暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
